SYNCOM FORMULATIONS (India) Today

Equity ratings for SYNCOM FORMULATIONS LT are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of December 2021 and ending today, the 28th of January 2022. Click here to learn more.
SYNCOM FORMULATIONS LT cannot be verified against its exchange. Apparently, SYNCOM FORMULATIONS is not available for investing at the moment. Please verify the symbol is currently traded on Bombay Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

SYNCOM FORMULATIONS Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. SYNCOM FORMULATIONS's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding SYNCOM FORMULATIONS or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
SYNCOM FORMULATIONS is not yet fully synchronised with the market data
SYNCOM FORMULATIONS has some characteristics of a very speculative penny stock
SYNCOM FORMULATIONS LT has accumulated about 78.74 M in cash with (16.01 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.11.
Legal NameSYNCOM FORMULATIONS LT
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of SYNCOM FORMULATIONS's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedUndervalued
SYNCOM FORMULATIONS LT (SYNCOMF) is traded on Bombay Stock Exchange in India and employs 803 people. The company currently falls under 'Small-Cap' category with current market capitalization of 562.07 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate SYNCOM FORMULATIONS's market, we take the total number of its shares issued and multiply it by SYNCOM FORMULATIONS's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. SYNCOM FORMULATIONS operates under Healthcare sector and is part of Drug Manufacturers - Major industry. The entity has 780.65 M outstanding shares. SYNCOM FORMULATIONS LT has accumulated about 78.74 M in cash with (16.01 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.11.
Check SYNCOM FORMULATIONS Probability Of Bankruptcy

SYNCOM Stock Against Markets

Picking the right benchmark for SYNCOM FORMULATIONS stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in SYNCOM FORMULATIONS stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for SYNCOM FORMULATIONS is critical whether you are bullish or bearish towards SYNCOM FORMULATIONS LT at a given time.
SYNCOM FORMULATIONS LT cannot be verified against its exchange. Apparently, SYNCOM FORMULATIONS is not available for investing at the moment. Please verify the symbol is currently traded on Bombay Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

Try Other Stock Suggestions

View Currently Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with SYNCOM FORMULATIONS stock to make a market-neutral strategy. Peer analysis of SYNCOM FORMULATIONS could also be used in its relative valuation, which is a method of valuing SYNCOM FORMULATIONS by comparing valuation metrics with similar companies.
Check out World Market Map. Note that the SYNCOM FORMULATIONS information on this page should be used as a complementary analysis to other SYNCOM FORMULATIONS's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Tools for SYNCOM Stock

When running SYNCOM FORMULATIONS price analysis, check to measure SYNCOM FORMULATIONS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SYNCOM FORMULATIONS is operating at the current time. Most of SYNCOM FORMULATIONS's value examination focuses on studying past and present price action to predict the probability of SYNCOM FORMULATIONS's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move SYNCOM FORMULATIONS's price. Additionally, you may evaluate how the addition of SYNCOM FORMULATIONS to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go